UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1326

2019

Link zum Volltext

Verfügbarkeit prüfen

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies

International journal of molecular sciences, 2019-10, Vol.20 (20), p.5010

2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

Cancer science, 2013-12, Vol.104 (12), p.1656-1661

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12708

2022

Link zum Volltext

Verfügbarkeit prüfen

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis

International journal of molecular sciences, 2018-03, Vol.19 (3), p.898

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5789

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Cancer science, 2012-03, Vol.103 (3), p.477-482

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Annals of hematology, 2012-05, Vol.91 (5), p.697-703

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement

Annals of hematology, 2021-05, Vol.100 (5), p.1221-1229

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of PARP inhibitors in ovarian cancer: therapeutic mechanisms and clinical data

European journal of gynaecological oncology, 2021-04, Vol.42 (2), p.199

2021

Link zum Volltext

Verfügbarkeit prüfen

Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?

International journal of gynecological cancer, 2017-09, Vol.27 (7), p.1431-1437

2017

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis

International journal of hematology, 2016-10, Vol.104 (4), p.476-484

2016

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation

British journal of haematology, 2014-06, Vol.165 (6), p.777-785

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma

Blood Research, 2021, 56(2), , pp.72-78

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma

European journal of haematology, 2014-11, Vol.93 (5), p.414-421

2014

Link zum Volltext

Verfügbarkeit prüfen

High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy

International journal of hematology, 2015-02, Vol.101 (2), p.140-147

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Prognostic Impact of DNMT3A Mutations in Korean Normal Karyotype Acute Myeloid Leukemia Patients

BioMed research international, 2015-01, Vol.2015, p.723682-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP

International journal of hematology, 2013-03, Vol.97 (3), p.397-402

2013

Link zum Volltext

Verfügbarkeit prüfen

Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population

Annals of Laboratory Medicine, 2015, 35(3), , pp.288-297

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

International journal of hematology, 2013-11, Vol.98 (5), p.543-548

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma

Journal of neuro-oncology, 2011-09, Vol.104 (3), p.825-831

2011

Link zum Volltext

Verfügbarkeit prüfen

A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy

Blood Research, 2015, 50(3), , pp.179-181

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea

Annals of Laboratory Medicine, 2015, 35(2), , pp.233-237

2015

Link zum Volltext

Verfügbarkeit prüfen

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Leukemia research, 2016-03, Vol.42, p.1-6

2016

Link zum Volltext

Verfügbarkeit prüfen

Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)

International journal of hematology, 2012-11, Vol.96 (5), p.631-637

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(97)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Humans
(54)
Aged
(48)
Male
(48)
Middle Aged
(48)
Female
(46)
Hematology
(41)
Adult
(39)
Oncology
(39)
Prognosis
(31)
Disease-Free Survival
(21)
Treatment Outcome
(21)
Retrospective Studies
(20)
Aged, 80 And Over
(19)
Young Adult
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Medicine
(17)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(16)
Medicine & Public Health
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis

Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement

The role of PARP inhibitors in ovarian cancer: therapeutic mechanisms and clinical data

Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?

Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis

Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation

Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma

Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma

High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy

Incidence and Prognostic Impact of DNMT3A Mutations in Korean Normal Karyotype Acute Myeloid Leukemia Patients

Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP

Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma

A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy

Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)

Suchergebnisse filtern